Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop
shivering in 90% of patients who experience shivering during scheduled elective cesarean
deliveries.